Who Supplies Rituximab? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Rituximab exports, with 164+ registered manufacturers shipping to buyers across 104+ countries — yet a handful of companies dominate the shipments. DR.REDDY'S LABORATORIES LTD holds the largest share at 27.5% (export value: $5.3M). Close behind, DR REDDYS LABORATORIES LIMITED (13.8%, $2.6M). RELIANCE LIFE SCIENCES PRIVATE LIMITED (11.0%, $2.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Rituximab? Top Manufacturers & Their Buyers
Flow of Rituximab from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Rituximab Supplier Network — Key Market Intelligence
The Rituximab export market from India is led by DR.REDDY'S LABORATORIES LTD, which alone commands a 27.5% share, shipping $5.3M worth of product across 64 shipments. The second-largest exporter, DR REDDYS LABORATORIES LIMITED, contributes $2.6M (13.8%) to the overall market. Combined, the top two suppliers alone account for 41.3% of all Rituximab exports, indicating a relatively concentrated supply base.
Across all 164 tracked manufacturers, the total Rituximab export value stands at $19.1M from 1.2K shipments. The market average shipment value is $15.7K. The single largest buyer relationship in terms of trade value is JSC R-PHARM, receiving $4.4M worth of product.
The combined buyer network spans 17 named purchasing companies, including JSC R-PHARM, DR.REDDYS LABORATORIES PHILIPPINES, HEALTHCARE PHARMACEUTICALS LTD.,, UPS WAREHOUSE, PT FERRON PAR PHARMA and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the first-largest Rituximab exporter from India, with a market share of 27.5% and a total export value of $5.3M across 64 shipments. Their average shipment value of $82.1K is above the market average of $15.7K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. JSC R-PHARM is the dominant customer, accounting for 83.5% of this supplier's tracked business. Top customers include:
• JSC R-PHARM — $4.4M across 53 shipments (83.5% of this supplier's total exports)
• DR.REDDYS LABORATORIES PHILIPPINES — $358.7K across 4 shipments (6.8% of this supplier's total exports)
• NA — $254.1K across 3 shipments (4.8% of this supplier's total exports)
• HEALTHCARE PHARMACEUTICALS LTD., — $160.7K across 2 shipments (3.1% of this supplier's total exports)
• UPS WAREHOUSE — $95.8K across 1 shipments (1.8% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $82.1K is 422% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.
2DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the second-largest Rituximab exporter from India, with a market share of 13.8% and a total export value of $2.6M across 11 shipments. Their average shipment value of $239.5K is above the market average of $15.7K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. JSC R-PHARM is the dominant customer, accounting for 91.5% of this supplier's tracked business. Top customers include:
• JSC R-PHARM — $2.4M across 10 shipments (91.5% of this supplier's total exports)
• UPS WAREHOUSE — $202.1K across 1 shipments (7.7% of this supplier's total exports)
• PT FERRON PAR PHARMA — $14.2K across 0 shipments (0.5% of this supplier's total exports)
• HYPERPHARM LTD — $7.9K across 0 shipments (0.3% of this supplier's total exports)
• JSC R-PHARM — $468 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $239.5K is 1422% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.
3RELIANCE LIFE SCIENCES PRIVATE LIMITED
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the third-largest Rituximab exporter from India, with a market share of 11.0% and a total export value of $2.1M across 102 shipments. Their average shipment value of $20.6K is above the market average of $15.7K, suggesting premium or bulk contract pricing.
RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• STATE PHARMACEUTICALS CORPORATION O — $596.8K across 29 shipments (28.5% of this supplier's total exports)
• LABORATORIOS LEGRAND S.A — $583.5K across 28 shipments (27.8% of this supplier's total exports)
• ABC PHARMA SERVICES (PVT) LTD — $430.6K across 21 shipments (20.5% of this supplier's total exports)
• DROGUERIA MK LAB S.A.C — $243.6K across 12 shipments (11.6% of this supplier's total exports)
• LABORATORIOS LEGRAND S.A — $242.5K across 12 shipments (11.6% of this supplier's total exports)
Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $20.6K is 31% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.
4MEDWISE OVERSEAS PRIVATE LIMITED
MEDWISE OVERSEAS PRIVATE LIMITED is the fourth-largest Rituximab exporter from India, with a market share of 5.7% and a total export value of $1.1M across 5 shipments. Their average shipment value of $216.3K is above the market average of $15.7K, suggesting premium or bulk contract pricing.
MEDWISE OVERSEAS PRIVATE LIMITED serves 2 named buyers in our database. TO is the dominant customer, accounting for 53.9% of this supplier's tracked business. Top customers include:
• TO — $583.1K across 3 shipments (53.9% of this supplier's total exports)
• TO — $498.3K across 2 shipments (46.1% of this supplier's total exports)
Key Insight: MEDWISE OVERSEAS PRIVATE LIMITED's per-shipment value of $216.3K is 1275% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.
5HETERO BIOPHARMA LIMITED
HETERO BIOPHARMA LIMITED is the fifth-largest Rituximab exporter from India, with a market share of 4.7% and a total export value of $901.0K across 8 shipments. Their average shipment value of $112.6K is above the market average of $15.7K, suggesting premium or bulk contract pricing.
HETERO BIOPHARMA LIMITED serves 5 named buyers in our database. XXAROXXPHAXXA SXX DXXC V is the dominant customer, accounting for 66.3% of this supplier's tracked business. Top customers include:
• XXAROXXPHAXXA SXX DXXC V — $597.2K across 5 shipments (66.3% of this supplier's total exports)
• XX SAXXE FXXMA — $128.7K across 1 shipments (14.3% of this supplier's total exports)
• XXVENXXHARXX S XXC — $76.3K across 1 shipments (8.5% of this supplier's total exports)
• XXVANXXD CXXMICXX IN — $57.7K across 1 shipments (6.4% of this supplier's total exports)
• XXCEPXX PHXXMACXXTIC — $41.1K across 0 shipments (4.6% of this supplier's total exports)
Key Insight: HETERO BIOPHARMA LIMITED's per-shipment value of $112.6K is 616% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.
6INVEX HEALTH PRIVATE LIMITED
INVEX HEALTH PRIVATE LIMITED is the fifth-largest Rituximab exporter from India, with a market share of 1.1% and a total export value of $202.1K across 3 shipments. Their average shipment value of $67.4K is above the market average of $15.7K, suggesting premium or bulk contract pricing.
INVEX HEALTH PRIVATE LIMITED serves 2 named buyers in our database. AFRI FARMACIA is the dominant customer, accounting for 70.8% of this supplier's tracked business. Top customers include:
• AFRI FARMACIA — $143.2K across 2 shipments (70.8% of this supplier's total exports)
• World Health Organiz — $59.0K across 1 shipments (29.2% of this supplier's total exports)
Key Insight: INVEX HEALTH PRIVATE LIMITED's per-shipment value of $67.4K is 328% above the market average of $15.7K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Rituximab Flows
Once Rituximab leaves the manufacturing plants of companies like DR.REDDY'S LABORATORIES LTD and DR REDDYS LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $19.1M. Russia absorbs the largest share at 47.2% ($9.0M), followed by Sri Lanka (11.3%) and Colombia (6.1%).
In Russia — the top destination — named importers include JSC R-PHARM. In Sri Lanka, key buyers are STATE PHARMACEUTICALS CORPORATION, STATE PHARMACEUTICALS CORPORATION O, ABC PHARMA SERVICES (PVT) LTD.
This geographic spread reflects Rituximab's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Rituximab Go? Top Importing Countries & Their Buyers
Trade flow of Rituximab exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia ranks as the first-largest destination for Rituximab imports from India, with a total trade value of $9.0M across 11 shipments — representing a 47.2% share of all Rituximab exports. The average shipment value of $820.3K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rituximab importers in Russia: JSC R-PHARM is the largest buyer, accounting for 73.3% ($6.6M) of this market's total imports.
• JSC R-PHARM — $6.6M (73.3% of Russia's total)
Key Insight: Russia's per-shipment average of $820.3K (5114% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Rituximab imports from India.
2Sri Lanka
Sri Lanka ranks as the second-largest destination for Rituximab imports from India, with a total trade value of $2.2M across 19 shipments — representing a 11.3% share of all Rituximab exports. The average shipment value of $113.7K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Rituximab importers in Sri Lanka: STATE PHARMACEUTICALS CORPORATION is the largest buyer, accounting for 38.9% ($839.8K) of this market's total imports.
• STATE PHARMACEUTICALS CORPORATION — $839.8K (38.9% of Sri Lanka's total)
• STATE PHARMACEUTICALS CORPORATION O — $596.8K (27.6% of Sri Lanka's total)
• ABC PHARMA SERVICES (PVT) LTD — $430.6K (19.9% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $113.7K (623% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Rituximab imports from India.
3Colombia
Colombia ranks as the third-largest destination for Rituximab imports from India, with a total trade value of $1.2M across 10 shipments — representing a 6.1% share of all Rituximab exports. The average shipment value of $117.4K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Rituximab importers in Colombia: LABORATORIOS LEGRAND S A is the largest buyer, accounting for 49.7% ($583.5K) of this market's total imports.
• LABORATORIOS LEGRAND S A — $583.5K (49.7% of Colombia's total)
• LABORATORIOS LEGRAND S.A — $376.4K (32.1% of Colombia's total)
Key Insight: Colombia's per-shipment average of $117.4K (646% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Colombia is a key market for Rituximab imports from India.
4Venezuela
Venezuela ranks as the fourth-largest destination for Rituximab imports from India, with a total trade value of $1.1M across 0 shipments — representing a 5.7% share of all Rituximab exports. The average shipment value of $1.1M is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Venezuela's per-shipment average of $1.1M (6794% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Venezuela is a key market for Rituximab imports from India.
5Mexico
Mexico ranks as the fifth-largest destination for Rituximab imports from India, with a total trade value of $719.8K across 2 shipments — representing a 3.8% share of all Rituximab exports. The average shipment value of $359.9K is above the global average of $15.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rituximab importers in Mexico: XXAROXXPHAXXA SXX DXXC V is the largest buyer, accounting for 83.0% ($597.2K) of this market's total imports.
• XXAROXXPHAXXA SXX DXXC V — $597.2K (83.0% of Mexico's total)
Key Insight: Mexico's per-shipment average of $359.9K (2188% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Rituximab imports from India.
People Also Ask — Rituximab Supplier & Trade Network
Who are the top suppliers of Rituximab from India?+
Which companies buy Rituximab from Indian manufacturers?+
Where does Rituximab exported from India go?+
What is the market share of the top Rituximab supplier from India?+
What is the average shipment value for Rituximab exports from India?+
Is Rituximab manufactured in India and exported globally?+
Which country imports the most Rituximab from India?+
Who are the buyers of Rituximab in Sri Lanka?+
How concentrated is the Rituximab supplier market in India?+
How do I find verified buyers for Rituximab in specific countries?+
Rituximab Trade Network — Key Takeaways
- 1DR.REDDY'S LABORATORIES LTD is India's dominant Rituximab exporter with a 27.5% market share and $5.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 164 suppliers collectively account for 63.7% of all tracked Rituximab exports, with a combined trade value of $19.1M.
- 3Russia is the largest destination market, absorbing 47.2% of India's Rituximab exports ($9.0M). Sri Lanka (11.3%) and Colombia (6.1%) follow.
- 4With 1.2K total shipments averaging $15.7K each, the Rituximab export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include JSC R-PHARM, DR.REDDYS LABORATORIES PHILIPPINES, JSC R-PHARM, UPS WAREHOUSE — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 104 countries
Network value: $19.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rituximab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Rituximab.
- 2.Flow Mapping: 164 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,215 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 104 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,215 Verified Shipments
164 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists